AdvaMed Statement on 14th Ministerial Meeting of the United States-India Trade Policy Forum

AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14^th Ministerial-level Trade Policy Forum held in New Delhi, India:

“Reinforcing a strong bilateral trading relationship with India is critical for our countries, and especially for the medtech manufacturers in the U.S. and India. I am glad to see Ambassador Tai and Minister Goyal continue to make progress on strengthening these ties during their most recent Ministerial-level discussions. Most notably, the cooperation between our two countries to diversify and strengthen supply chains and improve trading of high-tech products is welcome news as we continue to recover from pandemic-related challenges.

“AdvaMed and our members are also pleased with the ongoing discussions about Trade Margin Rationalization (TMR) to facilitate patient access to affordable medical devices and the recognition on both sides about the importance of addressing standards and pricing issues for medical devices. We continue to encourage both sides to undertake more in-depth work to foster greater regulatory harmonization and demonstrate progress towards adopting international standards that will reduce barriers to trade and strengthen supply chains.  

“AdvaMed also welcomes the launch of recent discussions on bilateral government procurement and is encouraged by Ambassador Tai and Minister Goyal’s plan for further technical engagement between their officials on transparency and procedural fairness.”

Read the joint statement from USTR Ambassador Tai and Minister Goyal here.